Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Cefadroxil vs Cephalexin in Pediatric MSK Infections
NCT03802552Phase 1Completed
- Sponsor
- University of Colorado Denver
- Start
- May 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cefadroxil in osteomyelitis (OM), septic arthritis and pyomyositis (2 arms), sponsored by University of Colorado Denver. Primary endpoint: Time above Minimum Inhibitory Concentration at 24 hours. Started May 2019; status: completed.
02
Drugs
cefadroxil
03
Conditions
osteomyelitis (OM)septic arthritispyomyositis
Beyond the preview
Go deeper on NCT03802552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03802552.